期刊文献+

siRNA沉默p28GANK对结肠癌细胞增殖的影响

Effect of p28GANK Silencing on the Proliferation of Colon Cancer Cells
下载PDF
导出
摘要 研究发现p28GANK表达与结肠癌恶性程度相关,其高表达提示预后不良。然而,p28GANK在结肠癌中的作用尚未完全明确。目的:探讨沉默p28GANK对结肠癌细胞增殖能力的影响。方法:以针对p28GANK基因的慢病毒携带siRNA转染人结肠癌HT29细胞,以蛋白质印迹法检测干扰效果,以MTT法检测细胞增殖,以平板克隆实验检测细胞克隆能力,以流式细胞术检测细胞周期变化。结果:与HT29、Con-HT29细胞相比,Si-HT29细胞中p28GANK蛋白表达水平显著降低;细胞增殖速度显著减缓;细胞克隆数量显著减少;G0/G1期细胞比例显著增多,S期细胞比例显著减少,PI值显著降低(P<0.05)。结论:沉默p28GANK在结肠癌细胞中的表达可抑制细胞增殖能力,使细胞周期阻滞。p28GANK可作为治疗结肠癌的新靶点。 Background: Study has shown that p28GANK expression is correlated with the degree of malignancy of colon cancer and its high expression indicates a poor prognosis. However, the role of p28GANK in colon cancer remains unclear. Aims: To investigate the effect of p28GANK silencing on proliferation of colon cancer cells. Methods : Lentivirus-mediated siRNA targeting p28GANK was transfected into colon cancer cell line HT29. The silencing effect was detected by Western blotting. Cell proliferation was detected by MTF. The cloning capability of cell was detected by plate colony formation assay. Cell cycle alteration was detected by flow cytometry. Results: The expression of p28GANK, the rate of cell proliferation and the number of cell clones were significantly decreased, and the proportion of cell in G0/G1 phase was significantly increased while that in S phase was significantly decreased, and the PI value was significantly decreased in Si-HT29 cells when compared with those in HT29 and Con-HT29 cells (P 〈 0.05). Conclusions: Silencing p28GANK can inhibit the proliferation of colon cancer ceils and block the cell cycle, p28GANK might be a potential target for colon cancer therapy.
出处 《胃肠病学》 2013年第12期733-737,共5页 Chinese Journal of Gastroenterology
关键词 p28GANK RNA 小分子干扰 结肠肿瘤 细胞增殖 p2$GANK RNA, Small Interfering Colonic Neoplasms Cell Proliferation
  • 相关文献

参考文献4

二级参考文献29

  • 1Shuang Ping Guo~1 Wen Liang Wang~1 Yu Qiang Zhai~2 Yi Ling Zhao~1 ~1Department of Pathology,Xijing Hospital of the Fourth Military Medical University,Xi’an,China ~2Department of Urology,the Central Hospital of Xi’an,China.Expression of nuclear factor-KB in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus[J].World Journal of Gastroenterology,2001,7(3):340-344. 被引量:55
  • 2Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 3Nakamura H, Kambe H, Egawa T, et al. Partial purification and characterization of human hepatoma- derived growth factor. Clin Chim Acta, 1989, 183 (3): 273-284.
  • 4Oliver JA, A1-Awqati Q. An endothelial growth factor involved in rat renal development. J Clin Invest, 1998, 102 (6): 1208-1219.
  • 5Yoshida K, Tomita Y, Okuda Y, et al. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma. Ann Surg Oncol, 2006, 13 (2): 159-167.
  • 6Yamamoto S, Tomita Y, Hoshida Y, et al. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Clin Cancer Res, 2006, 12 (1): 117-122.
  • 7Chang KC, Tai MH, Lin JW, et al. Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors. Int J Cancer, 2007, 121(5): 1059-1065.
  • 8Yamamoto S, Tomita Y, Hoshida Y, et al. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma. Ann Surg Oncol, 2007, 14 (7): 2141-2149.
  • 9Uyama H, Tomita Y, Nakamura H, et at. Hepatomaderived growth factor is a novel prognostic factor for patients with pancreatic cancer. Clin Cancer Res, 2006, 12 (20 Pt 1): 6043-6048.
  • 10Ren H, Tang X, Lee JJ, et al. Expression of hepatomaderived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol, 2004, 2 (16): 3230-3237.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部